Investors should prioritize Oscar Health (OSCR) as a high-conviction mid-term trade, as it currently trades at a massive valuation discount with projected 61% revenue growth. The Real Brokerage (REAX) offers a prime opportunity to play a future interest rate pivot, maintaining 51% growth despite macro headwinds and trading well below its historical value. In the fintech sector, NuBank (NU) is a top-tier growth pick as it expands into the U.S. market, while Webull (WEBLL) represents a significant value play compared to the more expensive Robinhood (HOOD). For those seeking healthcare exposure, Hims & Hers (HIMS) remains undervalued relative to its profitability and transparent pricing model even after its recent rally. Focus on companies with an EV/GP/RG metric under 0.5, as many high-growth disruptors in Fintech and Telehealth are currently being ignored by the broader market.

The Real Brokerage (REAX)

• The stock has declined 46% over the past 52 weeks, despite what the analyst describes as "stellar" growth and an annual report similar to SoFi. • It is currently trading at an EV/GP/RG (Enterprise Value over Gross Profit over Revenue Growth) of 0.048, which is significantly below the analyst's "good buy" threshold of 0.5. • The company maintains a Rule of 40 score of 54, indicating strong combined growth and profitability. • Current downward pressure is attributed to rising mortgage rates, but the company has continued to grow at 51% despite macro headwinds.

Takeaways

• Interest Rate Play: This is positioned as a primary play for when interest rate cuts eventually occur, which should act as a major catalyst for real estate volume. • Resilience: The business has proven it can grow in a high-interest-rate environment, suggesting significant upside if the macro environment improves.

Hims & Hers Health (HIMS)

• Despite a recent 50% rally, the stock remains inexpensive with an EV/GP/RG of 0.11. • The analyst notes that the "overhang" (legal threats and competition concerns regarding GLP-1/weight loss drugs) is largely gone. • The company boasts a Rule of 40 score of 43.

Takeaways

• Transparency Advantage: The company’s transparent pricing model is a competitive advantage over traditional healthcare providers. • Value Opportunity: Even after a price surge, the stock is considered undervalued relative to its growth profile.

Oscar Health (OSCR)

• Described as "super, super cheap" with an EV/GP/RG of 0.004, the lowest the analyst has seen. • Revenue growth is predicted at 61% for the next 12 months, driven by premium increases following the end of ACA (Obamacare) subsidies. • Management expresses high confidence that customers will prioritize health insurance payments over other expenses like car payments during financial stress.

Takeaways

• Mid-term Hold: The analyst views this as a mid-term trade rather than a long-term investment due to heavy regulation in the insurance industry. • Political Optionality: Potential for a "pop" in share price if ACA subsidies are expanded around the midterm elections.

Klarna (KLAR) / Affirm (AFRM) / Sezzle (SEZL)

• These "Buy Now, Pay Later" (BNPL) firms are gaining market share as Gen Z and Gen Alpha move away from traditional credit cards. • Klarna specifically is down 70%+ since its IPO, yet maintains a 48% gross margin and 16% EBITDA margin. • The analyst argues these models are superior to banks because the interest is often "sponsored" by the merchant rather than charged to the consumer.

Takeaways

• Disruption of "TradFi": These companies are viewed as more innovative and transparent than traditional banks like JP Morgan. • Approval Models: Their ability to be more stringent with loan approvals during risky periods (like the holiday season) makes them more resilient than permanent credit lines.

NuBank (NU) & SoFi (SOFI)

• Both are high-performing "Neobanks" with Rule of 40 scores of 75 (NuBank) and 59 (SoFi). • NuBank is currently expanding into the U.S. market, specifically targeting the Hispanic population in Florida. • SoFi is noted for being slightly less profitable and growing slower than NuBank, but it trades at a cheaper valuation.

Takeaways

• Market Expansion: NuBank’s move into the U.S. (Florida) is a major "selling point" and could significantly increase its economic weight. • Competitive Moat: Both companies are well-positioned to handle competition from emerging fintech players.

Webull (WEBLL) vs. Robinhood (HOOD)

• The analyst views Webull as a "copycat" of Robinhood that is being unfairly punished by the market. • Webull is trading at 12 times cheaper than Robinhood on an EV/EBITDA basis (5x vs 35x). • While smaller in total assets, Webull’s options trading volume is roughly 30% of Robinhood’s, which is significant given options are highly profitable.

Takeaways

• Relative Value Play: Robinhood is considered "expensive" at current levels (0.44 metric), while Webull is seen as a "steal" due to the massive valuation delta. • Sticky Business Model: Both platforms use marketing dollars to provide user bonuses, which effectively converts marketing spend directly into Assets Under Management (AUM).

Investment Themes & Sectors

The "Lost Decade" for Growth

• The analyst believes the 2020s are currently a "lost decade" where high-performing companies are not being rewarded with higher share prices due to macro fears (oil prices, inflation, 10-year treasury yields).

The "EV/GP/RG" Metric

• The analyst uses a specialized version of the PEG ratio: Enterprise Value / Gross Profit / Revenue Growth. • Benchmark: Under 0.5 is a "buy," and under 0.3 is a "really good buy." Many of the mentioned stocks are currently under 0.1.

Sector Sentiment

• Bullish: Fintech (Neobanks, BNPL), Telehealth, and Real Estate Tech. • Bearish/Neutral: Traditional "Value" stocks (Walmart, Costco), companies with high debt, and traditional "Too Big to Fail" banking institutions.